BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peng S, Shen L, Tian MX, Li HM, Wang SS. Poly(ADP-ribose) polymerase-1 inhibitor ameliorates dextran sulfate sodium-induced colitis in mice by regulating the balance of Th17/Treg cells and inhibiting the NF-κB signaling pathway. Exp Ther Med 2021;21:134. [PMID: 33376516 DOI: 10.3892/etm.2020.9566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Xia T, Li J, Ren X, Liu C, Sun C. Research progress of phenolic compounds regulating IL-6 to exert antitumor effects. Phytother Res 2021. [PMID: 34427003 DOI: 10.1002/ptr.7258] [Reference Citation Analysis]
2 Kovács D, Vántus VB, Vámos E, Kálmán N, Schicho R, Gallyas F, Radnai B. Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells. Oxid Med Cell Longev 2021;2021:7308897. [PMID: 34567413 DOI: 10.1155/2021/7308897] [Reference Citation Analysis]
3 Iqbal M, Ali EA, Kalam MA, Ahmad SF, Al-salahi R. Quantitative Determination of 5-Aminoisoquinoline, a PARP-1 Inhibitor by UPLC-MS/MS: In Silico ADME Profile and In Vitro Metabolic Stability Study. Applied Sciences 2022;12:5998. [DOI: 10.3390/app12125998] [Reference Citation Analysis]